Back to Search
Start Over
Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
- Source :
- Oncotarget
- Publication Year :
- 2018
- Publisher :
- Impact Journals, LLC, 2018.
-
Abstract
- // Katia Corano Scheri 1 , Erica Leonetti 1 , Luigi Laino 2 , Vincenzo Gigantino 3 , Luisa Gesualdi 1 , Paola Grammatico 2 , Mariano Bizzarri 4 , Renato Franco 5 , J. Wolter Oosterhuis 6 , Hans Stoop 6 , Leendert H.J. Looijenga 6 , Giulia Ricci 7, * and Angela Catizone 1, * 1 Department of Anatomy, Histology, Forensic-Medicine and Orthopaedics, “Sapienza” University of Rome, Italy 2 Department of Molecular Medicine, Laboratory of Medical Genetics, “Sapienza” University of Rome, San Camillo-Forlanini Hospital, Rome, Italy 3 Pathology Unit, Istituto Nazionale Tumori I.R.C.C.S. "Fondazione Pascale", Naples, Italy 4 Department of Experimental Medicine, Systems Biology Group Lab, “Sapienza” University of Rome, Italy 5 Pathological Anatomy Unit, Department of Psychic and Physic health and preventive medicine, Universita degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy 6 Department of Pathology, Laboratory for Experimental Patho-Oncology, Erasmus MC University Medical Center, Cancer Institute, Rotterdam, The Netherlands 7 Department of Experimental Medicine, Universita degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy * These authors contributed equally to this work Correspondence to: Giulia Ricci, email: giulia.ricci@unicampania.it Leendert H. J. Looijenga, email: l.looijenga@erasmusmc.nl Keywords: TGCTs; c-MET; HGF; c-MET inhibitors; cancer therapy Received: November 06, 2017 Accepted: July 18, 2018 Published: August 07, 2018 ABSTRACT Type II testicular germ cell tumors (TGCTs) represent the most frequent malignancy in Caucasian males (20–40 years). Even if diagnosed with disseminated disease, >80% of patients are cured; however, a small percentage of cases progress and result in death. It is commonly accepted that these cancers arise from a disturbed testicular embryonic niche that leads to the block of gonocyte differentiation. The subsequent development of the invasive seminomas and non-seminomas is due to a combination of genetic, epigenetic and microenvironment-based alterations (genvironment). Hepatocyte growth factor (HGF) is present in the testicular microenvironment, together with its receptor c-MET, from early embryonic development to an adult stage. In addition, c-MET is a well-known proto-oncogene involved in the onset and progression of various human cancers. Herein, we have investigated the expression and availability of HGF and c-MET in TCam-2, NCCIT and NT2D1 cells, which are type II (T)GCT representative cell lines, and the effect of c-MET activation/repression on the regulation of cancerous biological processes. We found that NT2D1 cells increase their proliferation, polarized migration, and invasion in response to HGF administration. NCCIT cells respond to HGF stimulation only partially, whereas TCam-2 cells do not respond to HGF, at least according to the investigated parameters. Interestingly, the immunohistochemical study of c-MET distribution in TGCTs confirm its presence in both seminoma and non-seminoma lesions with different patterns. Notably, we found the highest c-MET immunoreactivity in the epithelial elements of the various components of TGCTs: teratoma, yolk sac tumor and choriocarcinoma.
- Subjects :
- 0301 basic medicine
Oncology
medicine.medical_specialty
C-Met
TGCTs
Malignancy
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Internal medicine
medicine
HGF
c-MET
c-MET inhibitors
business.industry
Choriocarcinoma
Correction
Cancer
Seminoma
medicine.disease
Molecular medicine
humanities
030104 developmental biology
chemistry
030220 oncology & carcinogenesis
cancer therapy
Hepatocyte growth factor
Teratoma
business
Research Paper
medicine.drug
Subjects
Details
- ISSN :
- 19492553
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Oncotarget
- Accession number :
- edsair.doi.dedup.....cea04a89d19cfbb08b7b25b6c3d1dea2
- Full Text :
- https://doi.org/10.18632/oncotarget.26374